Cargando…

Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy

BACKGROUND: The therapeutic effects of adipose-derived mesenchymal stromal cells (ADSCs) may be mainly mediated by their paracrine effects. The ADSC-secretome can ameliorate hepatic ischemia–reperfusion injury (IRI). We explored the therapeutic effect of the ADSC-secretome from the perspective of ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yajun, Jiao, Zhihui, Liu, Xiaoning, Zhang, Qianzhen, Piao, Chenxi, Xu, Jiayuan, Wang, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392224/
https://www.ncbi.nlm.nih.gov/pubmed/35987696
http://dx.doi.org/10.1186/s13287-022-03109-2
_version_ 1784771016364392448
author Ma, Yajun
Jiao, Zhihui
Liu, Xiaoning
Zhang, Qianzhen
Piao, Chenxi
Xu, Jiayuan
Wang, Hongbin
author_facet Ma, Yajun
Jiao, Zhihui
Liu, Xiaoning
Zhang, Qianzhen
Piao, Chenxi
Xu, Jiayuan
Wang, Hongbin
author_sort Ma, Yajun
collection PubMed
description BACKGROUND: The therapeutic effects of adipose-derived mesenchymal stromal cells (ADSCs) may be mainly mediated by their paracrine effects. The ADSC-secretome can ameliorate hepatic ischemia–reperfusion injury (IRI). We explored the therapeutic effect of the ADSC-secretome from the perspective of excessive hepatocyte autophagy induced by hepatic IRI. METHODS: We established a miniature pig model of hepatic ischemia–reperfusion (I/R) and hepatectomy using a laparoscopic technique and transplanted ADSCs and the ADSC-secretome into the liver parenchyma immediately after surgery. Liver injury and hepatocyte autophagy were evaluated by histopathological examination and assessment of relevant cytokines and other factors. RESULTS: The results showed that the ADSC-secretome alleviated the pathological changes of liver tissue and the microstructural damage of hepatocytes after IRI. Moreover, the expression levels of autophagy-related markers including Beclin-1, ATG5, ATG12, and LC3II/LC3I decreased, whereas those of p62 increased during phagophore expansion. Furthermore, the expression levels of markers related to the autophagy inhibition pathway phosphatidylinositol-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR), including PI3K, Akt, and mTOR, increased. CONCLUSION: The ADSC-secretome attenuates hepatic I/R and hepatectomy-induced liver damage by inhibiting autophagy, which is possibly mediated by activation of the PI3K/Akt/mTOR signaling pathway. In addition, there was no significant difference between ADSCs and the ADSC-secretome in the regulation of hepatocyte autophagy. Therefore, ADSCs may improve the excessive autophagy-induced injury of hepatocytes in hepatic I/R and hepatectomy through paracrine effect. Our findings provide new insight into the therapeutic potential of cell-free products, which could replace cell therapy in liver diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03109-2.
format Online
Article
Text
id pubmed-9392224
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93922242022-08-21 Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy Ma, Yajun Jiao, Zhihui Liu, Xiaoning Zhang, Qianzhen Piao, Chenxi Xu, Jiayuan Wang, Hongbin Stem Cell Res Ther Research BACKGROUND: The therapeutic effects of adipose-derived mesenchymal stromal cells (ADSCs) may be mainly mediated by their paracrine effects. The ADSC-secretome can ameliorate hepatic ischemia–reperfusion injury (IRI). We explored the therapeutic effect of the ADSC-secretome from the perspective of excessive hepatocyte autophagy induced by hepatic IRI. METHODS: We established a miniature pig model of hepatic ischemia–reperfusion (I/R) and hepatectomy using a laparoscopic technique and transplanted ADSCs and the ADSC-secretome into the liver parenchyma immediately after surgery. Liver injury and hepatocyte autophagy were evaluated by histopathological examination and assessment of relevant cytokines and other factors. RESULTS: The results showed that the ADSC-secretome alleviated the pathological changes of liver tissue and the microstructural damage of hepatocytes after IRI. Moreover, the expression levels of autophagy-related markers including Beclin-1, ATG5, ATG12, and LC3II/LC3I decreased, whereas those of p62 increased during phagophore expansion. Furthermore, the expression levels of markers related to the autophagy inhibition pathway phosphatidylinositol-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR), including PI3K, Akt, and mTOR, increased. CONCLUSION: The ADSC-secretome attenuates hepatic I/R and hepatectomy-induced liver damage by inhibiting autophagy, which is possibly mediated by activation of the PI3K/Akt/mTOR signaling pathway. In addition, there was no significant difference between ADSCs and the ADSC-secretome in the regulation of hepatocyte autophagy. Therefore, ADSCs may improve the excessive autophagy-induced injury of hepatocytes in hepatic I/R and hepatectomy through paracrine effect. Our findings provide new insight into the therapeutic potential of cell-free products, which could replace cell therapy in liver diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03109-2. BioMed Central 2022-08-20 /pmc/articles/PMC9392224/ /pubmed/35987696 http://dx.doi.org/10.1186/s13287-022-03109-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ma, Yajun
Jiao, Zhihui
Liu, Xiaoning
Zhang, Qianzhen
Piao, Chenxi
Xu, Jiayuan
Wang, Hongbin
Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy
title Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy
title_full Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy
title_fullStr Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy
title_full_unstemmed Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy
title_short Protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy
title_sort protective effect of adipose-derived stromal cell-secretome attenuate autophagy induced by liver ischemia–reperfusion and partial hepatectomy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392224/
https://www.ncbi.nlm.nih.gov/pubmed/35987696
http://dx.doi.org/10.1186/s13287-022-03109-2
work_keys_str_mv AT mayajun protectiveeffectofadiposederivedstromalcellsecretomeattenuateautophagyinducedbyliverischemiareperfusionandpartialhepatectomy
AT jiaozhihui protectiveeffectofadiposederivedstromalcellsecretomeattenuateautophagyinducedbyliverischemiareperfusionandpartialhepatectomy
AT liuxiaoning protectiveeffectofadiposederivedstromalcellsecretomeattenuateautophagyinducedbyliverischemiareperfusionandpartialhepatectomy
AT zhangqianzhen protectiveeffectofadiposederivedstromalcellsecretomeattenuateautophagyinducedbyliverischemiareperfusionandpartialhepatectomy
AT piaochenxi protectiveeffectofadiposederivedstromalcellsecretomeattenuateautophagyinducedbyliverischemiareperfusionandpartialhepatectomy
AT xujiayuan protectiveeffectofadiposederivedstromalcellsecretomeattenuateautophagyinducedbyliverischemiareperfusionandpartialhepatectomy
AT wanghongbin protectiveeffectofadiposederivedstromalcellsecretomeattenuateautophagyinducedbyliverischemiareperfusionandpartialhepatectomy